Invention Publication
- Patent Title: Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
-
Application No.: US18383310Application Date: 2023-10-24
-
Publication No.: US20240182557A1Publication Date: 2024-06-06
- Inventor: Jewel Johanns , Katherine Li , Colleen Marano , Richard Strauss , Hongyan Zhang , Christopher O'Brien , Omoniyi Adedokun , Kimberly Shields-Tuttle
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- The original application number of the division: US16580509 2019.09.24
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K9/00 ; A61K9/08 ; A61K39/00 ; A61K47/18 ; A61K47/22 ; A61K47/26 ; A61P1/04
Abstract:
Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.
Information query
